Gujarat Themis Biosyn to acquire Japan’s MicroBiopharm for ₹1,300 crore
Gujarat Themis Biosyn Ltd (GTBL) on Friday (May 22) said it has entered into a definitive agreement to acquire 100% equity shareholding of Japan-based MicroBiopharm Japan Co, Ltd (MBJ) through Themis Biosyn Japan Ltd, its wholly-owned subsidiary incorporated in Japan. The acquisition, subject to regulatory approvals and customary closing formalities, will be completed for a…
